Internal Medicine · El Dorado, KS
NPI
1750728838
Since 2013
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
700 W Central Ave, Suite 201
El Dorado, KS, 67042
Phone (316) 321-2100
Groups this clinician bills Medicare through
Medicare paid, 2024
$72K
1,695 services
Medicare patients, 2024
354
Average age 75
Drug cost, 2024
$865K
11,534 prescriptions
Company payments, 2025
$1,646
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Allison J Sollo was code 99214 (office e&m - established), 529 times for 187 patients. In total Allison J Sollo billed 1,695 services in 17 codes, and Medicare paid $72K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-10-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 529 | 187 | $77.69 | $41K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 449 | 163 | $11.30 | $5,074 |
| 93010 Electrocardiogram | Facility | 184 | 137 | $5.24 | $964 |
| 99213 Office E&M - Established | Office | 116 | 78 | $52.24 | $6,060 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 112 | 112 | $118.45 | $13K |
| 96160 E&M - Miscellaneous | Office | 78 | 78 | $1.92 | $150 |
| 99204 Office E&M - New | Office | 19 | 19 | $108.97 | $2,070 |
| 93248 Electrocardiogram | Facility | 13 | 13 | $18.89 | $246 |
By year: 2022 $71K for 1,122 services; 2023 $67K for 1,132 services; 2024 $72K for 1,695 services.
Medicare prescription drug claims, 2024
In 2024, the drug Allison J Sollo prescribed most often to Medicare patients was Atorvastatin Calcium, with 547 prescriptions and refills. In total Allison J Sollo wrote 11,534 Medicare prescriptions that cost $865K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 547 | 1,110 | 121 | $2,782 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 376 | 376 | 90 | $9,299 |
| Lisinopril Generic | 349 | 716 | 79 | $1,664 |
| Levothyroxine Sodium Generic | 348 | 659 | 65 | $1,979 |
| Omeprazole Generic | 345 | 616 | 68 | $4,263 |
| Gabapentin Generic | 267 | 376 | 51 | $3,034 |
| Potassium Chloride Generic | 266 | 392 | 49 | $3,908 |
| Sertraline Hcl Generic | 250 | 420 | 43 | $1,728 |
| Pantoprazole Sodium Generic | 240 | 396 | 49 | $2,298 |
| Losartan Potassium Generic | 207 | 462 | 51 | $1,267 |
| Furosemide Generic | 203 | 297 | 36 | $507 |
| Cyclobenzaprine Hcl Generic | 200 | 222 | 50 | $1,290 |
| Metoprolol Tartrate Generic | 199 | 386 | 43 | $807 |
| Trazodone Hcl Generic | 199 | 276 | 40 | $1,186 |
| Amlodipine Besylate Generic | 199 | 443 | 49 | $851 |
Brand drugs: 1,424 claims; generic drugs: 9,998 claims; opioid claims: 792.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Allison J Sollo $1,646 ($1,646 in general payments such as food, travel and fees) from 21 companies. The largest payer was Abbvie Inc. with $181.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 10 | $181 |
| Novo Nordisk Inc NVO | 9 | $180 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $172 |
| Pfizer Inc. PFE | 12 | $146 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 7 | $122 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 6 | $117 |
| Sumitomo Pharma America, Inc. 4506.T | 4 | $107 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 4 | $84.29 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 4 | $69.38 |
| Abbott Laboratories ABT | 3 | $68.44 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.